These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25927971)
1. Monte Carlo modelling of daylight activated photodynamic therapy. Campbell CL; Wood K; Valentine RM; Brown CT; Moseley H Phys Med Biol; 2015 May; 60(10):4059-73. PubMed ID: 25927971 [TBL] [Abstract][Full Text] [Related]
2. Modelling topical photodynamic therapy treatment including the continuous production of Protoporphyrin IX. Campbell CL; Brown CT; Wood K; Moseley H Phys Med Biol; 2016 Nov; 61(21):7507-7521. PubMed ID: 27716646 [TBL] [Abstract][Full Text] [Related]
3. Quantifying the radiant exposure and effective dose in patients treated for actinic keratoses with topical photodynamic therapy using daylight and LED white light. Manley M; Collins P; Gray L; O'Gorman S; McCavana J Phys Med Biol; 2018 Jan; 63(3):035013. PubMed ID: 29192611 [TBL] [Abstract][Full Text] [Related]
5. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison. LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548 [TBL] [Abstract][Full Text] [Related]
6. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study. Petersen B; Wiegell SR; Wulf HC Br J Dermatol; 2014 Jul; 171(1):175-8. PubMed ID: 24506809 [TBL] [Abstract][Full Text] [Related]
7. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318 [TBL] [Abstract][Full Text] [Related]
8. Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy. Ruiz AJ; LaRochelle EPM; Samkoe KS; Chapman MS; Pogue BW Photodiagnosis Photodyn Ther; 2023 Mar; 41():103260. PubMed ID: 36627070 [TBL] [Abstract][Full Text] [Related]
9. Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ. de Souza ALR; LaRochelle E; Marra K; Gunn J; Davis SC; Samkoe KS; Chapman MS; Maytin EV; Hasan T; Pogue BW Photodiagnosis Photodyn Ther; 2017 Dec; 20():227-233. PubMed ID: 29037911 [TBL] [Abstract][Full Text] [Related]
10. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130 [TBL] [Abstract][Full Text] [Related]
11. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses. Wiegell SR; Heydenreich J; Fabricius S; Wulf HC Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730 [TBL] [Abstract][Full Text] [Related]
12. Intense pulse light and 5-ALA PDT: phototoxic effects in vitro depend on the spectral overlap with protoporphyrine IX but do not match cut-off filter notations. Maisch T; Moor AC; Regensburger J; Ortland C; Szeimies RM; Bäumler W Lasers Surg Med; 2011 Feb; 43(2):176-82. PubMed ID: 21384398 [TBL] [Abstract][Full Text] [Related]
13. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661 [TBL] [Abstract][Full Text] [Related]
14. The background and philosophy behind daylight photodynamic therapy. Wulf HC G Ital Dermatol Venereol; 2018 Dec; 153(6):776-782. PubMed ID: 29683283 [TBL] [Abstract][Full Text] [Related]
15. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas. Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097 [TBL] [Abstract][Full Text] [Related]
16. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen. Liu B; Farrell TJ; Patterson MS Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331 [TBL] [Abstract][Full Text] [Related]
17. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells. Novak B; Heesen L; Schary N; Lübbert H Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796 [TBL] [Abstract][Full Text] [Related]
18. A consensus on the use of daylight photodynamic therapy in the UK. Ibbotson S; Stones R; Bowling J; Campbell S; Kownacki S; Sivaramakrishnan M; Valentine R; Morton CA J Dermatolog Treat; 2017 Jun; 28(4):360-367. PubMed ID: 27788605 [TBL] [Abstract][Full Text] [Related]
19. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial. O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523 [TBL] [Abstract][Full Text] [Related]
20. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]